You are here:

  1. Home
  2. NICE guidance
  3. In development

Efgartigimod for treating chronic inflammatory demyelinating polyneuropathy [ID6409]

  • In development
  • Reference number: GID-TA11508
  • Expected publication date:  17 September 2026
  • Project information
  • Project documents
  • Consultation

On this page

  1. Draft guidance
  2. Invitation to participate
  3. Notes
  4. Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6409
  5. Topic selection

Documents

Documents created during the development process.

Draft guidance

  • Draft guidance

  • Draft guidance (online commenting)

  • Draft guidance (downloadable version) (PDF 311 KB)

    Published:
    24 April 2026
  • Committee papers (ACM1) (PDF 7.82 MB)

    Published:
    24 April 2026
  • Public committee slides (ACM1) (PDF 856 KB)

    Published:
    24 April 2026
  • Equality impact assessment (DG) (PDF 123 KB)

    Published:
    24 April 2026

Invitation to participate

  • Final scope (PDF 120 KB)

    Published:
    14 August 2025
  • NICE's response to comments on the draft scope and provisional stakeholder list (PDF 348 KB)

    Published:
    14 August 2025
  • Equality impact assessment (scoping) (PDF 102 KB)

    Published:
    14 August 2025
  • Final stakeholder list (PDF 134 KB)

    Published:
    14 August 2025

Notes

  • Note

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6409

  • Draft scope post referral (PDF 176 KB)

    Published:
    01 November 2024
  • Draft matrix post referral (PDF 177 KB)

    Published:
    01 November 2024

Topic selection

  • Topic selection

Back to top